Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Abstract

Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4 + and CD8 + T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4 + and CD8 + T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4 + and CD8 + T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals ≥ 65 years old. Scarcity of naive T cells was also associated with aging and poor disease outcomes. A parsimonious explanation is that coordinated CD4 + T cell, CD8 + T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between aging and impaired adaptive immune responses to SARS-CoV-2.

Cited by papers we hold 42

• Changes in peripheral blood mononuclear cell electrical properties in response to viral exposure and vaccination · 2025
  Not checked
• Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 · 2024
  No notice
• T‐cell activation–induced marker assays in health and disease · 2023
  No notice
• Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system · 2023
  No notice
• Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission · 2022
  No notice
• A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron · 2022
  Not checked
• Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients · 2022
  Not checked
• Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine · 2022
  Not checked
• T cell apoptosis characterizes severe Covid-19 disease · 2022
  No notice
• T cell responses to SARS-CoV-2 spike cross-recognize Omicron · 2022
  Corrected
• Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant · 2022
  No notice
• Adaptive Immune Responses and Immunity to SARS-CoV-2 · 2022
  No notice
• Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants · 2022
  No notice
• The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines · 2022
  No notice
• Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms · 2021
  No notice
• ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models · 2021
  Not checked
• SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells · 2021
  No notice
• Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model · 2021
  Not checked
• Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset · 2021
  Not checked
• Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level · 2021
  Not checked

and 22 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.